Anthropic eyes in-house drug discovery with Claude Science AI platform

1 min read
Source: The Verge
Anthropic eyes in-house drug discovery with Claude Science AI platform
Photo: The Verge
TL;DR Summary

Anthropic unveiled Claude Science, an AI workbench for scientists, and signaled plans to develop its own drugs—targeting neglected diseases—while continuing to sell AI tools to biotech and pharma customers. Experts say AI can accelerate drug discovery but human oversight, data gaps, and regulatory hurdles mean any AI-designed drug is likely years away.

Share this article

Reading Insights

Total Reads

1

Unique Readers

13

Time Saved

6 min

vs 6 min read

Condensed

96%

1,18952 words

Want the full story? Read the original article

Read on The Verge